Work

IDH1 mutation predicts response and survival in treatment-naïve Acute Myeloid Leukemia patients receiving with venetoclax with a hypomethylating agent

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-7032

Authors: Sarvarinder Gill, Shuqi Wang, Jamie Koprivnikar, Katherine Linder, Ayrton Bangolo, Behzad Amoozgar, Lili Zhang, James McCloskey

Institutions: Hackensack University Medical Center, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417014968

Cites:

Cited by:

Related to: